These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3108221)

  • 1. The antitumor potency of oral tegafur against adenocarcinoma 755 in mice is markedly enhanced by oral (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Iigo M; Yamaizumi Z; Nishimura S; Hoshi A; De Clercq E
    Jpn J Cancer Res; 1987 Apr; 78(4):409-13. PubMed ID: 3108221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in mice.
    Iigo M; Nakajima Y; Hoshi A; De Clercq E
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):773-7. PubMed ID: 3115784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
    Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.
    Okabe H; Toko T; Saito H; Nakano K; Fujioka A; Yuasa C; Takeda S; Unemi N
    Anticancer Res; 1997; 17(1A):157-64. PubMed ID: 9066646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
    Sekiguchi I; Suzuki M; Tamada T; Nishida M
    Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
    Fukushima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice.
    Desgranges C; Razaka G; De Clercq E; Herdewijn P; Balzarini J; Drouillet F; Bricaud H
    Cancer Res; 1986 Mar; 46(3):1094-101. PubMed ID: 3943086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of the chemotherapeutic action of tegafur against solid adenocarcinoma 755 by combination with L-cystine.
    Iigo M; Hoshi A; Kitagawa H
    J Cancer Res Clin Oncol; 1986; 111(3):187-90. PubMed ID: 3090050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental studies on the antitumor effect of oral antitumor agents on gynecological malignant tumors].
    Suzuki M; Sekiguchi I; Tamada T; Nishida M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):31-5. PubMed ID: 3102648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.
    Desgranges C; Razaka G; Drouillet F; Bricaud H; Herdewijn P; De Clercq E
    Nucleic Acids Res; 1984 Feb; 12(4):2081-90. PubMed ID: 6701093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats].
    Komatsumoto M; Li S; Hamada J; Takeichi N; Hosokawa M; Okayasu T; Tanabe T; Kobayashi H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1739-45. PubMed ID: 3130810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Keizer HJ; De Bruijn EA; Tjaden UR; De Clercq E
    J Cancer Res Clin Oncol; 1994; 120(9):545-9. PubMed ID: 8045919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of UFT on experimental liver metastases and on the immunologic capacity of the hosts].
    Tsuru S; Togami M; Taniguchi M; Nomoto K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1915-20. PubMed ID: 3132895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy with cyclophosphamide and ftorafur against advanced L1210 murine leukemia.
    Grossie VB; Rosenblum MG; Loo TL
    Cancer Treat Rep; 1982 Aug; 66(8):1631-4. PubMed ID: 6809329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S; Baccanari DP; Joyner SS; Davis ST; Rustum YM; Spector T
    Cancer Res; 1995 Dec; 55(24):6227-30. PubMed ID: 8521418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
    Shirasaka T; Nakano K; Takechi T; Satake H; Uchida J; Fujioka A; Saito H; Okabe H; Oyama K; Takeda S; Unemi N; Fukushima M
    Cancer Res; 1996 Jun; 56(11):2602-6. PubMed ID: 8653704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents.
    Fujii S; Kitano S; Ikenaka K; Shirasaka T
    Gan; 1979 Apr; 70(2):209-14. PubMed ID: 381088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
    Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
    Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.